Azithromycin for Preventing Maternal and Neonatal Infections During Labor.

Launched by ARMED FORCES HOSPITAL, PAKISTAN · Apr 28, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the use of an antibiotic called azithromycin to see if it can help prevent infections in mothers and newborns during labor. The researchers want to find out if giving this medication to the mother while she is in labor can reduce the chances of infections that can be harmful for both the mother and the baby.

To be eligible for this trial, women must be pregnant and going into labor (either naturally or induced) without any known risk factors for infections. This means they should not have signs of infection like fever or a high white blood cell count, and they should not have had any serious reactions to similar medications in the past. If you participate in this trial, you will receive the antibiotic during labor, and the study will monitor you and your baby to see how well it works. This trial is not yet recruiting participants, but it aims to gather important information that could improve care for mothers and newborns during childbirth.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • pregnant ladies with no risk factors for sepsis who go into spontaneous labor or induced labor
• Exclusion Criteria:
• • pregnant with risk factors for sepsis like maternal fever , raised WBC count, chorioamnionitis, or having. history of any adverse even with macrolides